NFATc4 knockout in mice enhances RGC survival and delays axonal degeneration following optic nerve injury by suppressing pro-apoptotic signaling, highlighting NFATc4 as a potential therapeutic target for optic neuropathies [203]. This evidence concerns the gene NFATC4 and Optic neuropathy.